Movano (Movano) Growth Rank : 0 (As of Apr. 27, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Movano Growth Rank?

Movano has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Movano Growth Rank Related Terms

Thank you for viewing the detailed overview of Movano's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Movano (Movano) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Movano Inc (NAS:MOVE) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

6800 Koll Center Parkway, Pleasanton, CA, USA, 94566

Website

https://www.movano.com

Movano Inc is a health-focused technology company developing simple, smart, and personalized devices designed to help individuals on their health journey maintain good health today and prevent and manage chronic diseases in the future. It is developing a proprietary platform that uses Radio Frequency (RF) technology. It enables the creation of low-cost and scalable sensors that fit into wearable and other small form factors.

Executives

Jeremy Cogan	officer: CFO	6800 KOLL CENTER PARKWAY, PLEASANTON CA 94566
Michael Aaron Leabman	director, officer: CEO and President	207 VERITAS CT, SAN RAMON CA 94582
Emily Fairbairn	director	10 ORINDA VIEW ROAD, ORINDA CA 94563
John Mastrototaro	director	6800 KOLL CENTER PARKWAY, PLEASANTON CA 94566
Brian Cullinan	officer: CFO	6800 KOLL CENTER PARKWAY, PLEASANTON CA 94566
Nan Kirsten Forte	director	111 EIGHTH AVENUE, NEW YORK NY 10011
Ruben Caballero	director	C/O RESONANT INC. 10900 STONELAKE BLVD., SUITE 100, OFFICE 02-130, AUSTIN TX 78759
Dvine Irrevocable Trust	10 percent owner	6200 STONERIDGE MALL RD., SUITE 300, PLEASANTON CA 94588
Gregory S Tamkin	10 percent owner	303 RAY STREET, PLEASANTON CA 94566
Dorsey & Whitney Trust Co Llc	10 percent owner	401 EAST EIGHTH STREET, SUITE 319, SIOUX FALLS SD 57103
William Tai-wei Ho	10 percent owner	C/O IN8BIO, INC., 79 MADISON AVENUE, NEW YORK NY 10016